Together with our thyroid partners, we ran a survey in November 2019 to look into the prescribing practices of CCGs across England since the NHS England guidance was published – the T3 Prescribing Survey 2019.  Our survey clearly shows that there are still many CCGs withdrawing or not allowing the prescribing of liothyronine even though the NHS England and the RMOC guidance both state “not routinely prescribed”.  This does not mean “must not be prescribed”.

The survey is available to read here.